Quintiles Chief: Australia Needs To Back Investment In Medical Research
This article was originally published in PharmAsia News
Executive Summary
The CEO of Quintiles Transnational Corp. says Australia is well-placed to take advantage of China's growing R&D, biotech and pharmaceutical investments